Accelerate Your Preclinical Research By InnoSer’s Innovative Methods.

Customizing in-vitro and in-vivo services for your success.

Recently At InnoSer

InnoSers Ongoing Commitment to the 3R’s

by Casey | April 13, 2021 | Blog, Services | 0 Comments

Throughout modern medicine animal testing has played a critical role in the development of drugs, vaccines, and surgical techniques. These studies have enabled us to save countless lives and build upon research to ultimately cure patients. Aiming to accelerate the...

InnoSer is at AACR with its Oncology Offerings

by Casey | April 7, 2021 | Events, News | 0 Comments

Innoser is putting oncology development at the forefront of our efforts this year. By attending this year's AACR 2021, we hope to improve our innovative oncology offerings and learn from the best. This year the American Association for Cancer Research is hosting its...

Quality Management At InnoSer Services

by admin | April 5, 2021 | Blog, Services | 0 Comments

As InnoSer transitions from the startup to scale up phase in its journey, it is also taking a number of steps to ascertain its quality management ambitions. Having dedicated personnel, expanding our current list of certifications, organizing formal audits and...

THERAPEUTIC AREAS

We Specialize In

InnoSer’s INNOVATIVE METHODS

Combining In-Vivo And In-Vitro

By our state-of-the-art methods from organoids to genetically engineered mice, we provide reliability and transferability in your results.

Low success rates of drugs that are able to go from bench to the clinic continue to disappoint not only researchers and pharmaceutical companies but also patients and their families. The resulting expenses affect the costs of all drugs that reach the market.

This calls for more stringent criteria at the preclinical phase, ensuring only the drugs that are effective and safe for humans continue to the clinical phases. InnoSer excels in combining in vitro and in vivo disease modelling to offer the most reliable screening platforms.

By developing in-vitro technologies and knowledge that offer higher predictive capacity, we support the transition to a world that relies less on animal testing.

SERVICES OVERVIEW

GET IN TOUCH WITH US

Tell Us About Your Work

We always keep close contact with our customers to identify and understand their needs better. All our services can be customized for your project requirements.

START A CONVERSATION

OUR CLIENTS ABOUT US

Academic And Commercial Expertise

“We truly enjoyed working with the InnoSer team. They bring an outstanding scientific knowledge into the oncology field in combination with high flexibility. InnoSer provided us with and executed a preclinical study project tailored to our needs, and within the agreed timelines. We will definitely work with InnoSer for our future drug development needs.”

Ad van de Gorp PhD, CEO Cythura Therapeutics

“Starting a biotech company was something completely new for me. InnoSer supported me in developing the study protocol and with all additional hassle like ethical protocols, logistics, ordering study materials etc. We worked closely with the InnoSer staff and I truly appreciate their professionalism and dedication.”

Joost van Bree, CEO Saillant Therapeutics

SEE ALL TESTIMONIALS



Phone

+32 (0)11 14 07 68



Headquarters

InnoSer België NV

Agoralaan A bis
3590 Diepenbeek
Belgium



Email

info@innoserlaboratories.com



Subsidiary

InnoSer Nederland BV

Zernikedreef 9
2333 CK Leiden
The Netherlands